Educational content only. This describes how private-equity-backed consolidation of independent healthcare practices is generally structured, valued, and regulated in the US and Canada. It is not legal, tax, financial, or transaction advice, recommends no specific decision, structure, or party, and takes no position on whether any owner should sell or retain a practice. Deal terms, valuations, and the rules governing practice ownership vary by deal, specialty, province, and state, and change over time. Consult qualified legal, tax, and transaction advisors before evaluating any offer.
An independent practice owner today is increasingly likely to receive an acquisition offer that does not come from another clinician. It comes from a corporate entity, usually backed by private equity, that buys or affiliates with practices at scale. The offer often carries a headline number larger than any individual buyer would pay. It frequently arrives unsolicited, and sometimes comes with a short window to respond. For an owner who has spent a career thinking of a practice sale as a transaction between two clinicians, it is an unfamiliar kind of decision arriving in an unfamiliar form.
This pattern is no longer specific to one field. Over roughly two decades it moved through dentistry, then optometry and ophthalmology, then physical therapy, veterinary medicine, dermatology, and gastroenterology. It is now reaching into behavioral health, primary care, and specialties that consolidators describe as being in their early stages. The mechanics stay remarkably consistent from one specialty to the next, even though the name on the offer letter changes. Understanding those mechanics is what lets an owner read an offer for what it contains rather than what its cover page advertises: what these organizations are, how they value a practice, how the offer is actually built, and how the regulatory ground differs between the US and Canada. This is a description of that machinery. It is not a case for taking such an offer or for refusing one. Both can be the right decision depending on facts this article cannot see.
What These Organizations Are, and Why the Structure Looks the Way It Does
The entity making the offer is, in most cases, a management organization. It provides the non-clinical functions of running a practice across a network of affiliated or owned locations: billing, payroll, human resources, marketing, procurement, technology, compliance, and management. The clinical work stays with licensed practitioners. The business infrastructure is centralized and run at scale. The economic logic is straightforward and not, in itself, sinister. Spread overhead across many locations, buy supplies and equipment with group purchasing power, and bring professional management to practices that were often run by clinicians improvising as business operators.
The structure takes its particular two-entity form for a regulatory reason, and it is the same reason in both countries. Most US states uphold some version of the corporate practice of medicine doctrine, which prohibits non-clinicians and corporations from owning a clinical practice or employing the clinicians who deliver care. The standard structure built to operate within that prohibition pairs a management services organization with a clinician-owned professional entity. The professional corporation, owned by a licensed clinician, holds the clinical side and remains responsible for all care. The management services organization, which can be owned by investors, holds the business. It acquires the non-clinical assets, employs the non-clinical staff, and provides services to the practice under a long-term management services agreement in exchange for a management fee. The investor takes an ownership stake in the management organization and, through it, captures the business economics, while a licensed clinician remains the owner of record on the clinical side.
This is worth stating plainly, because it is the single most misunderstood feature of these transactions. When an owner sells to a consolidator, the buyer is typically not buying the clinical practice the way an individual clinician would. The buyer is acquiring or controlling the management organization, and the clinical entity enters a long-term agreement with it. What an owner is actually negotiating is frequently the management services agreement, the employment agreement, and the terms of any retained equity, not a simple transfer of the practice. The documents are the deal. The brochure is not.
The Regulatory Split: Why US Content Misleads a Canadian Owner
Almost everything written about healthcare consolidation describes the US market, and a Canadian owner who reads it as if it applies directly is being misled on the most important structural point. The two countries arrive at similar two-entity structures for similar reasons, but the rules differ in ways that change both what is permissible and what a deal is worth after tax.
In Canada, provincial regulators of each profession generally require that licensed members maintain ownership and control of the clinical practice through a professional corporation, and the rules governing who may hold shares in that corporation are set province by province. In several provinces the requirements are strict. Voting shares of the professional corporation must be held by licensed members of the profession, with non-voting shares often limited to a member's family. A holding company or outside investor typically cannot hold voting shares in the professional corporation directly. The result is the same structural workaround seen in the US. The consolidator owns the non-clinical business and equipment, provides management under a services agreement, and contracts with a licensed practitioner who holds the professional entity. But the precise architecture, and how much non-clinician involvement is permissible, varies by province. A structure that is workable in one province may not be permissible in another, which makes the province a first-order variable in any Canadian transaction rather than a footnote.
There is a second Canadian dimension with no US equivalent, and it can change the after-tax math entirely. The Lifetime Capital Gains Exemption can shelter a substantial amount of gain on the sale of qualifying small business corporation shares, and the way a consolidation deal is structured determines whether a seller can access it. Two offers with the same headline number can produce materially different after-tax outcomes depending on how each is structured against that exemption and against the seller's professional corporation. This is precisely the kind of consideration that does not appear in US-written content, and that an owner relying on US material would never think to ask about.
The Canadian market also sits at an earlier point on the same curve. Corporate ownership penetration varies widely by field. A small single-digit share of dental practices, a larger share of optometry, a substantial share of veterinary clinics, and a majority of pharmacies have come under corporate or consolidator ownership, and well-capitalized organizations continue to expand. The trajectory mirrors the US, several years behind. An owner planning a sale a decade out is making that plan in a market whose buyer landscape is still actively forming.
How Consolidators Value a Practice
Consolidators value practices differently from individual clinicians, and the difference is central to reading an offer.
An individual buyer typically values a practice on a percentage of collections or revenue, a model rooted in buying a practice as a job. A consolidator values on a multiple of EBITDA, meaning earnings before interest, taxes, depreciation, and amortization, normalized to reflect what the practice earns as a business once the owner's above-market compensation and personal expenses are adjusted out. This is the same lens a lender or any institutional buyer applies, and it produces a fundamentally different number from a collections multiple. An owner who has only ever heard practices discussed as "a percentage of collections" is, on receiving a consolidator offer, being valued on an entirely different basis, and should understand the translation.
Reported multiples vary by specialty and, more than anything, by scale. Single-location practices and small add-on acquisitions are generally cited at lower multiples of normalized EBITDA. Multi-location groups and platform-scale practices, those with management depth and earnings in the millions, command meaningfully higher multiples. The single largest driver of the multiple is size. Moving from one location to several can change both the EBITDA figure and the multiple applied to it. This is the structural reason consolidators pursue a "platform-and-add-on" strategy, acquiring an initial platform practice and then rolling smaller surrounding practices into it. It is also why an owner who builds a small group before selling often realizes a materially larger exit than one who sells a single location.
The multiple is not a market entitlement. It is the output of an underwriting process. A buyer starts with collections, tests whether they convert into durable cash flow, normalizes owner and provider economics, examines provider concentration and payer mix, and only then selects a multiple reflecting the risk-adjusted earnings. Two practices with identical collections can be treated very differently after diligence. The factors that most often reduce the multiple are concentration risk where the practice depends heavily on the selling owner's personal production, declining recent EBITDA, and heavy reliance on a single payer or referral source. A practice where the owner personally generates most of the production is specifically discounted, because those earnings risk walking out the door when the owner eventually does.
The Structure of the Offer
One thing to understand about a consolidator offer is that the headline number and the realized number are often different, and the difference comes from how the total is structured. The total is typically assembled from several components, and only one of them is guaranteed.
Cash at closing. A portion of the total, paid upfront. This is the part that is actually guaranteed and actually the seller's. It deserves the most weight in any evaluation, because it is the only component that does not depend on future events.
Holdback and earnout. A portion withheld at closing and paid over time, contingent on the practice maintaining revenue or EBITDA targets, and often on the selling clinician completing a multi-year post-closing employment commitment. This portion is at risk. It depends on hitting targets the seller no longer fully controls once they are an employee within a larger organization rather than the owner setting the practice's direction.
Rollover equity. A portion paid not in cash but as equity in the consolidator or its parent. This is usually positioned as the part that makes the economics compelling, the prospect of a "second bite of the apple" when the platform is eventually sold to the next investor at a higher multiple. It is also the component most often illiquid, subject to forfeiture conditions, governed by restrictive agreements, and dependent on a future capital event that may arrive later than projected, at a different valuation than modeled, or under terms set by parties other than the seller.
Running through all of it is the employment commitment. Most consolidation structures require the selling clinician to keep practicing for a defined period, commonly several years, considerably longer than the brief transition an individual buyer would request. The earnout and often the rollover are tied to that commitment, which means a meaningful share of the headline total is conditional on the seller continuing to work, under new ownership, for years after closing.
How to Read the Headline on Consistent Terms
A consolidator offer and an individual-buyer offer are quoted on different bases, and comparing them requires putting both onto the same footing first.
When a clinician buys a practice, the price is consideration for the practice itself: its patients, cash flow, equipment, and goodwill. The buyer's price does not include the seller's future earnings, because the seller either leaves or negotiates a go-forward role as a separate matter. Compensation for working is treated as what it is, payment for labor, not part of the sale.
A consolidator offer is built from the same underlying asset value, but it is frequently quoted as a single multi-year total that can blend several distinct things: the consideration for the practice, the at-risk earnout and rollover equity, and, in some presentations, the compensation the clinician will earn for continuing to practice after closing. The first of these is transaction value. The last is operating compensation for future work. They are different line items that happen to appear in the same figure.
For an owner comparing options, the useful step is to unbundle the consolidator figure back to the part that is actually consideration for the practice, the guaranteed cash plus a discounted, risk-adjusted value of the earnout and rollover, and to set the future practice compensation aside as the separate operational item it is. Done that way, the consolidator offer and the individual-buyer offer can finally be compared on the same basis: what each pays for the asset. This is not a claim that any figure is presented in bad faith. It is the normalization a lender or an analyst performs by habit. Separate the return on the asset from the return on labor, and value the asset on its own terms.
This is not an argument for either choice. It is a method. An owner who applies it reads every offer more clearly, whichever way they ultimately decide.
How This Varies Across Specialties
The machinery above is common to most fields, but the texture differs, and the differences matter to an owner trying to locate their own situation on the curve.
Dentistry is the most mature consolidation market in both countries, organized around dental support organizations. In Canada the largest operate at meaningful scale, and the structure is shaped by provincial professional-corporation rules. Some run majority dentist-owned networks, others integrate practices more fully. Dental's long head start means an owner there faces the most developed bid environment and the most established deal templates.
Optometry and ophthalmology followed dentistry closely, with eye care among the most heavily consolidated fields. A large share of practice transactions in ophthalmology over recent years have been investor-driven, and optometry has its own established corporate networks. Physical therapy and rehabilitation, veterinary medicine, and dermatology are each well into the cycle, with dermatology somewhat newer and still actively forming platforms. Behavioral and mental health, primary care, and several procedure-heavy specialties are described by consolidators as earlier-stage, with a longer runway of acquisition ahead. Owners in those fields may see rising offer activity rather than a settled market.
Two structural patterns generalize across all of them. First, specialties with significant elective, cash-pay, or ancillary revenue tend to attract more investor interest, because that revenue is less constrained by third-party reimbursement and more amenable to growth. The optical dispensary, the aesthetic procedure, and the diagnostic add-on are all examples. Second, the more a specialty's economics depend on a single owner's personal production rather than a transferable system of providers and recurring patients, the more concentration risk discounts the multiple. An owner assessing where their own practice sits can reason from those two patterns even in a field this article has not named specifically.
The Contested Context an Owner Should Know
Consolidation is not a settled or uncontroversial development within the professions, and an owner evaluating an offer is doing so inside an active debate that is worth seeing clearly.
On one side, consolidators and many of the owners who have sold point to real benefits: access to growth capital, relief from administrative burden, group purchasing power, professional management, and, in markets with few individual buyers, a genuine exit that might not otherwise exist. For an owner nearing retirement with no internal successor, or one who wants to keep practicing without running a business, these can be substantial and real.
On the other side, a growing body of research and a number of professional and regulatory bodies have raised concerns. Peer-reviewed studies of private-equity acquisitions in several specialties have associated them with increased healthcare spending, and some have found shifts in staffing toward non-physician providers. Regulators and competition authorities in both countries have begun examining the market-concentration effects of roll-ups, including the possibility of higher prices and reduced competition where a consolidator gains significant local market share. Within the professions, some practitioners view the trend as a threat to clinical independence and to the character of independent practice itself. These concerns are real, they are contested in turn, and they are part of the environment in which any offer is made. An owner does not have to resolve the larger debate to make a sound decision about a single practice, but it is worth knowing the debate exists and is not one-sided.
There is also a competitive dimension beyond the personal sell-or-hold question. As consolidators assemble a local market, they reshape the competitive dynamics, the labor market for associates and staff, and the field of future buyers. The same demand that lifts the multiples available to a seller can, in major metros, make it harder for an early-career clinician to buy in as an individual. That is part of why associate-to-owner transitions, minority buy-ins, and partnership structures have grown more important as paths to ownership against corporate competition. The consolidation that widens a seller's exit options can narrow a buyer's entry options.
The Bottom Line
The rise of private-equity-backed consolidation has changed what it means to own and to sell an independent healthcare practice. It has done so across nearly every specialty, faster in the US than in Canada, where provincial rules requiring clinician ownership shape the corporate structure into something genuinely distinct from the American model. For an owner who receives an offer, the essential discipline is the same regardless of field. Understand which model is actually on the table. Read the management services agreement and employment terms for what autonomy and equity are really being retained. Separate the guaranteed cash from the at-risk earnout and the illiquid rollover. And unbundle any future practice compensation from the transaction figure, so a consolidator offer and an individual-buyer offer can be compared on what each actually pays for the asset. Underneath the unfamiliar form, the decision is the one it has always been: what the practice is worth as an asset, and what an owner nets for it now versus later. Seen that way, it becomes a financial decision to be made on normalized numbers and qualified advice, not on the size of the number at the top of the offer letter.
A consolidator offer is an EBITDA-multiple question, and reading it well starts with understanding your own normalized earnings. The Practice Valuation Reference shows how multiples are applied to normalized EBITDA. The Profitability Calculator models the operating profit a retained practice keeps, which is the other side of the sell-versus-hold equity comparison. Both free, with separate Canadian and US models, no account required.
Disclaimer: This content is general and educational and varies by deal, specialty, province, and state. Valuation ranges, deal structures, and regulatory rules described reflect general market patterns and change over time. This content is not legal, tax, financial, or transaction advice, recommends no specific decision or party, and does not constitute brokerage or advisory services. Consult qualified legal, tax, and transaction professionals before evaluating any offer.